Jan 24, 2022 8:00 am EST Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treatment of Homocystinuria
Dec 15, 2021 8:00 am EST Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing
Nov 22, 2021 8:00 am EST Codexis Presents Pre-Clinical Data Highlighting its Programs in Homocystinuria and Maple Syrup Urine Disease at ICIEM 2021
Nov 15, 2021 8:00 am EST Codexis to Present Data Highlighting Two New Therapeutic Discovery Programs at the 14th International Congress of Inborn Errors of Metabolism 2021
Nov 15, 2021 8:00 am EST Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development
Nov 04, 2021 8:00 am EDT The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.